A phase I evaluation of N10-propargyl-5,8-dideazafolic acid

This publication has 5 references indexed in Scilit:

• A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
  Journal of Clinical Oncology, 1986
• Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717
  British Journal of Cancer, 1986
• The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)
  Cancer Chemotherapy and Pharmacology, 1985
• PATTERNS OF CROSS-RESISTANCE TO THE ANTI-FOLATE DRUGS TRIMETREXATE, METOPRINE, HOMOFOLATE, AND CB3717 IN HUMAN LYMPHOMA AND OSTEO-SARCOMA CELLS RESISTANT TO METHOTREXATE
  1983
• A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
  Published by Elsevier ,1981